Disorders of Lipid Metabolism in Chronic Kidney Disease

Area of Science:

• Nephrology
• Cardiology
• Biochemistry

Background:

• Cardiovascular disease (CVD) is the primary cause of mortality in chronic kidney disease (CKD).
• Atherosclerotic plaque formation is accelerated in CKD due to factors including hyperlipidemia, uremic toxins, inflammation, oxidative stress, and endothelial dysfunction.
• Declining kidney function is associated with increased oxidized low-density lipoprotein cholesterol and dysfunctional high-density lipoprotein cholesterol.

Purpose of the Study:

• To review the impact of kidney dysfunction on lipid profiles.
• To examine the roles of oxidative stress and inflammation in altering lipid profiles in CKD patients.

Main Methods:

• Literature review of recent studies on CKD, CVD, and lipid metabolism.
• Analysis of pathophysiological mechanisms linking kidney dysfunction to dyslipidemia.
• Synthesis of findings on oxidative stress and inflammation's effects on lipoproteins.

Main Results:

• Kidney dysfunction significantly impacts lipid profiles, contributing to CVD risk.
• Oxidative stress and inflammation exacerbate dyslipidemia in CKD.
• Specific alterations include increased oxidized LDL and impaired HDL function.

Conclusions:

• Kidney dysfunction, oxidative stress, and inflammation are key drivers of dyslipidemia in CKD.
• Understanding these mechanisms is crucial for managing CVD risk in CKD patients.
• Targeting these pathways may offer therapeutic strategies for reducing cardiovascular mortality in CKD.